177 related articles for article (PubMed ID: 11155099)
21. Octreotide exerts only acute, but no sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome.
Zomerhuis MT; Hussain SM; Feelders RA; van der Lely AJ; de Herder WW
Neuroendocrinology; 2005; 82(1):41-8. PubMed ID: 16391492
[TBL] [Abstract][Full Text] [Related]
22. Metastatic carcinoid tumor--atypical presentation.
Pleşa A; Sarca E; Maxim R
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1018-23. PubMed ID: 25581963
[TBL] [Abstract][Full Text] [Related]
23. [Multiple carcinoid tumors of the small intestine].
Tordjmann T; Fléjou JF; Ruszniewski P; Belghiti J; Bernades P
Gastroenterol Clin Biol; 1995 May; 19(5):534-6. PubMed ID: 7590007
[TBL] [Abstract][Full Text] [Related]
24. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
[TBL] [Abstract][Full Text] [Related]
25. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.
Siu LL; Chapman W; Moore MJ
Am J Clin Oncol; 1997 Dec; 20(6):558-61. PubMed ID: 9391539
[TBL] [Abstract][Full Text] [Related]
26. Testicular metastasis from ileal carcinoid: report of a case.
Danikas D; Sachs R; Dressner RM; Arvanitis ML
Dis Colon Rectum; 2001 Sep; 44(9):1365-6. PubMed ID: 11584217
[TBL] [Abstract][Full Text] [Related]
27. Carcinoid-associated ectopic ACTH syndrome with variable response to octreotide.
Gill GV; Yong A; Power E; Ramage J
Postgrad Med J; 1999 Feb; 75(880):98-100. PubMed ID: 10448471
[TBL] [Abstract][Full Text] [Related]
28. Long-standing malignant pancreatic carcinoid treated with octreotide.
Varas-Lorenzo MJ
Rev Esp Enferm Dig; 2010 Nov; 102(11):662-6. PubMed ID: 21142389
[TBL] [Abstract][Full Text] [Related]
29. Octreotide therapy in carcinoid disease.
Bax ND; Woods HF; Batchelor A; Jennings M
Anticancer Drugs; 1996 Jan; 7 Suppl 1():17-22. PubMed ID: 8822081
[TBL] [Abstract][Full Text] [Related]
30. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix.
Koch CA; Azumi N; Furlong MA; Jha RC; Kehoe TE; Trowbridge CH; O'Dorisio TM; Chrousos GP; Clement SC
J Clin Endocrinol Metab; 1999 Nov; 84(11):4209-13. PubMed ID: 10566674
[TBL] [Abstract][Full Text] [Related]
31. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
32. Management of enterochromaffin-like gastric carcinoid tumour metastasized to the liver.
Kouraklis G; Misiakos E; Glinavou A; Raftopoulos J; Karatzas G
Scand J Gastroenterol; 2002 Feb; 37(2):246-8. PubMed ID: 11843065
[TBL] [Abstract][Full Text] [Related]
33. [A case of multiple liver metastasis from ileac carcinoid effectively treated with continuous intraarterial infusion of somatostatin analog].
Wadamori K; Oka M; Shimizu R; Tangoku A; Hazama S; Yagyu T; Suzuki T; Hatano S; Kurokawa F; Okita K
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1669-72. PubMed ID: 7574789
[TBL] [Abstract][Full Text] [Related]
34. [Enteral hyperoxalosis due to therapy with a somatostatin analog].
Ranft K; Eibl-Eibesfeldt B
Dtsch Med Wochenschr; 1990 Feb; 115(5):179-81. PubMed ID: 2298134
[TBL] [Abstract][Full Text] [Related]
35. Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy.
Khan MQ; Al Kahtani KM; Al-Ashgar H
Ann Saudi Med; 2004; 24(5):386-90. PubMed ID: 15573856
[No Abstract] [Full Text] [Related]
36. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract][Full Text] [Related]
37. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
Linkesch M; Kuzmits R; Geyer G
Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
[TBL] [Abstract][Full Text] [Related]
38. Treatment with octreotide to suppress corticotropin secretion by a carcinoid tumour.
Tirovola EB; Malpas JS
J R Soc Med; 2005 Nov; 98(11):516. PubMed ID: 16260804
[No Abstract] [Full Text] [Related]
39. The importance of follow-up examinations in patients with carcinoid tumor.
Szilvás A; Székely G; Szilvási I; Sági S; Jakab F
Hepatogastroenterology; 2003; 50(53):1452-3. PubMed ID: 14571761
[TBL] [Abstract][Full Text] [Related]
40. [Prevention of carcinoid tumor crisis].
Kriváchy P; Szabó K; Koiss I; Bálint A
Orv Hetil; 1992 Jan; 133(3):163-6. PubMed ID: 1346472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
